Managing ICU Arrhythmias: Rapid Rate Control Strategies Using β1-Selective Agents скачать в хорошем качестве

Managing ICU Arrhythmias: Rapid Rate Control Strategies Using β1-Selective Agents

View this SCCM webcast recording for dynamic, case-driven discussions that dive into the complexities of managing new-onset atrial fibrillation in critically ill patients. Expert faculty will unpack the pharmacologic nuances of beta-antagonists in the ICU setting and deliver actionable insights to help you optimize hemodynamic stability when it matters most. This webcast is supported by AOP Health. Learning Objectives • Apply evidence-based strategies in case-based scenarios for rate control in critically ill patients with new-onset atrial fibrillation to support safe and effective ICU management • Explain the pharmacologic characteristics and mechanism of action of a β1-antagonist for the short-term reduction of ventricular rate in adult patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter Subject Matter Experts: Jean-Luc Fellahi, MD, PhD Professor of Anaesthesiology and Critical Care Louis Pradel University Hospital Lyon, France Michael R. Bristow, MD, PHD Director, Section of Pharmacogenomics, CU-CVI University of Colorado Cardiovascular Institute Professor of Medicine (Cardiology) University of Colorado School of Medicine Aurora, Colorado, USA Moderator: Emily Highsmith, PharmD, BCCCP Critical Care Clinical Pharmacist MD Anderson Cancer Center University of Texas Houston, Texas, USA The views and opinions expressed are those of the sponsor and do not necessarily reflect the views or opinions of SCCM. References to specific commercial entities, products, tests, procedures, opinions, resources, and information do not reflect SCCM’s review or endorsement.